Adverse events (AEs) with maintenance olaparib in patients with a germline BRCA mutation (gBRCAm) and metastatic pancreatic cancer (mPaC): Phase III POLO trial.

Michele  Reni

Honoraria - Baxalta/Shire; Baxalta/Shire; Baxalta/Shire; Baxalta/Shire

Consulting or Advisory Role - Baxalta/Shire; Baxalta/Shire; Baxalta/Shire; Baxalta/Shire; Celgene; Celgene; Celgene; Celgene; Novartis; Novartis; Novartis; Novartis; Novocure; Novocure; Novocure; Novocure; Pfizer; Pfizer; Pfizer; Pfizer

Research Funding - Celgene; Celgene; Celgene; Celgene

Travel, Accommodations, Expenses - Celgene; Celgene; Celgene; Celgene

Hedy L.  Kindler

Consulting or Advisory Role - Aldeyra Therapeutics; Aldeyra Therapeutics; Aldeyra Therapeutics; Aldeyra Therapeutics; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; ipsen; ipsen; ipsen; ipsen; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Merck; Merck; Merck; Merck; Paradox Therapeutics; Paradox Therapeutics; Paradox Therapeutics; Paradox Therapeutics

Research Funding - Aduro Biotech (Inst); Aduro Biotech (Inst); Aduro Biotech (Inst); Aduro Biotech (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); Deciphera (Inst); Deciphera (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Inhibrx (Inst); Inhibrx (Inst); Inhibrx (Inst); Inhibrx (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Polaris (Inst); Polaris (Inst); Polaris (Inst); Polaris (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Verastem (Inst); Verastem (Inst); Verastem (Inst); Verastem (Inst)

Pascal  Hammel

Honoraria - Celgene; Celgene; Celgene; Celgene

Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Celgene; Celgene; Celgene; Celgene; ERYTECH Pharma (Inst); ERYTECH Pharma (Inst); ERYTECH Pharma (Inst); ERYTECH Pharma (Inst); Halozyme; Halozyme; Halozyme; Halozyme; Shire; Shire; Shire; Shire; VECT-HORUS; VECT-HORUS; VECT-HORUS; VECT-HORUS

Speakers' Bureau - Celgene; Celgene; Celgene; Celgene; Shire; Shire; Shire; Shire

Travel, Accommodations, Expenses - Halozyme; Halozyme; Halozyme; Halozyme; Ipsen; Ipsen; Ipsen; Ipsen; Lilly; Lilly; Lilly; Lilly; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Shire; Shire; Shire; Shire

Eric  Van Cutsem

Consulting or Advisory Role - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Halozyme; Halozyme; Halozyme; Halozyme; Lilly; Lilly; Lilly; Lilly; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER

Research Funding - amgen (Inst); amgen (Inst); amgen (Inst); amgen (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst)

Teresa  Macarulla

No Relationships to Disclose

Michael J.  Hall

Research Funding - Ambry Genetics; Ambry Genetics; Ambry Genetics; Ambry Genetics; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; InVitae; InVitae; InVitae; InVitae; Myriad Genetics; Myriad Genetics; Myriad Genetics; Myriad Genetics

Patents, Royalties, Other Intellectual Property - I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst); I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst); I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst); I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst)

Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Myriad Genetics; Myriad Genetics; Myriad Genetics; Myriad Genetics

Other Relationship - Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Invitae; Invitae; Invitae; Invitae; Myriad Genetics; Myriad Genetics; Myriad Genetics; Myriad Genetics

Joon Oh  Park

Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Celgene; Celgene; Celgene; Celgene; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER; Shire; Shire; Shire; Shire

Speakers' Bureau - Celgene; Celgene; Celgene; Celgene

Research Funding - Celgene; Celgene; Celgene; Celgene

Daniel  Hochhauser

Stock and Other Ownership Interests  - Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche

Research Funding - Merck Serono; Merck Serono; Merck Serono; Merck Serono

Travel, Accommodations, Expenses - Celgene; Celgene; Celgene; Celgene

Dirk  Arnold

Honoraria - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Biocompatibles; Biocompatibles; Biocompatibles; Biocompatibles; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; Lilly; Lilly; Lilly; MSD; MSD; MSD; MSD; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; Servier; Servier; Servier; Servier; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical; TERUMO; TERUMO; TERUMO; TERUMO

(OPTIONAL) Uncompensated Relationships - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD; MSD; MSD; MSD; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical

Do-Youn  Oh

Honoraria - ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; Bayer; Bayer; Bayer; Bayer; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Halozyme; Halozyme; Halozyme; Halozyme; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Novartis; Novartis; Novartis; Novartis; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical

Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca

Anke C.  Reinacher-Schick

Honoraria - Amgen; Amgen; Amgen; Amgen; Aurikamed; Aurikamed; Aurikamed; Aurikamed; Baxalta; Baxalta; Baxalta; Baxalta; BOVita; BOVita; BOVita; BOVita; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; iomedico; iomedico; iomedico; iomedico; Lilly; Lilly; Lilly; Lilly; MCI Group; MCI Group; MCI Group; MCI Group; med publico; med publico; med publico; med publico; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD; MSD; MSD; MSD; Pfizer; Pfizer; Pfizer; Pfizer; Promedior; Promedior; Promedior; Promedior; Roche; Roche; Roche; Roche; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; SERVIER; SERVIER; SERVIER; SERVIER; Shire; Shire; Shire; Shire

Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Baxalta; Baxalta; Baxalta; Baxalta; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD; MSD; MSD; MSD; Onkowissen; Onkowissen; Onkowissen; Onkowissen; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; SERVIER; SERVIER; SERVIER; SERVIER

Research Funding - AIO-Studien (Inst); AIO-Studien (Inst); AIO-Studien (Inst); AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Alexion Pharmaceuticals (Inst); Alexion Pharmaceuticals (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Georgius Agricola Stiftung Ruhr (Inst); Georgius Agricola Stiftung Ruhr (Inst); Georgius Agricola Stiftung Ruhr (Inst); Georgius Agricola Stiftung Ruhr (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Ludwig Maximilian University of Munich (Inst); Ludwig Maximilian University of Munich (Inst); Ludwig Maximilian University of Munich (Inst); Ludwig Maximilian University of Munich (Inst); MOLOGEN (Inst); MOLOGEN (Inst); MOLOGEN (Inst); MOLOGEN (Inst); Pharma Consulting Group AB (Inst); Pharma Consulting Group AB (Inst); Pharma Consulting Group AB (Inst); Pharma Consulting Group AB (Inst); PPD Global (Inst); PPD Global (Inst); PPD Global (Inst); PPD Global (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Servier (Inst); Servier (Inst); Servier (Inst); Servier (Inst); Syneed Medidata (Inst); Syneed Medidata (Inst); Syneed Medidata (Inst); Syneed Medidata (Inst); University of Cologne (Inst); University of Cologne (Inst); University of Cologne (Inst); University of Cologne (Inst); University of Erlangen-Nuremberg (Inst); University of Erlangen-Nuremberg (Inst); University of Erlangen-Nuremberg (Inst); University of Erlangen-Nuremberg (Inst)

Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; MCI Group; MCI Group; MCI Group; MCI Group; Onkowissen; Onkowissen; Onkowissen; Onkowissen; Roche; Roche; Roche; Roche; Servier; Servier; Servier; Servier

Giampaolo  Tortora

Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; Merck Serono; Merck Serono; Merck Serono; Merck Serono

Travel, Accommodations, Expenses - Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche

Hana  Algül

Honoraria - Celgene; Celgene; Celgene; Celgene; SERVIER; SERVIER; SERVIER; SERVIER

Research Funding - Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma

(OPTIONAL) Uncompensated Relationships - Lilly; Lilly; Lilly; Lilly; Revolution Medicines; Revolution Medicines; Revolution Medicines; Revolution Medicines

Eileen Mary  O'Reilly

Consulting or Advisory Role - Ipsen; Ipsen; Ipsen; Ipsen; Merck; Merck; Merck; Merck

Research Funding - AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst)

David  McGuinness

No Relationships to Disclose

Karen  Cui

Employment - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca

Stock and Other Ownership Interests  - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene

Katia  Schlienger

Employment - Merck; Merck; Merck; Merck

Stock and Other Ownership Interests  - Merck; Merck; Merck; Merck

Travel, Accommodations, Expenses - Merck; Merck; Merck; Merck

Gershon Y.  Locker

Employment - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca

Stock and Other Ownership Interests  - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca

Talia  Golan

Honoraria - MSD; MSD; MSD; MSD; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals

Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca

Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); MSD Oncology (Inst); MSD Oncology (Inst); MSD Oncology (Inst); MSD Oncology (Inst)